Bob Morrow over at the Transparent Medical Practice blog always seems to come up with something provocative. The other day he was questioning the notion of therapeutic inertia. That's a construct that's been used to describe underutilization of evidence based therapies, often pharmacologic. Bob wonders if it's just a drug company pitch.
OK, look. It doesn't have to be either/or. It's been well documented that many life saving therapies (heart failure drugs and pharmacologic DVT prophylaxis to name a couple) are vastly underutilized, resulting in needless suffering and loss of life. Increase doctors' adherence to best practice, patients benefit and, yes, the drug companies are happy. Nothing inherently wrong there.